Effects of glioblastoma-derived extracellular vesicles on the functions of immune cells.
Ontology highlight
ABSTRACT: Glioblastoma is the most aggressive variant of glioma, the tumor of glial origin which accounts for 80% of brain tumors. Glioblastoma is characterized by astoundingly poor prognosis for patients; a combination of surgery, chemo- and radiotherapy used for clinical treatment of glioblastoma almost inevitably results in rapid relapse and development of more aggressive and therapy resistant tumor. Recently, it was demonstrated that extracellular vesicles produced by glioblastoma (GBM-EVs) during apoptotic cell death can bind to surrounding cells and change their phenotype to more aggressive. GBM-EVs participate also in establishment of immune suppressive microenvironment that protects glioblastoma from antigen-specific recognition and killing by T cells. In this review, we collected present da
SUBMITTER: Musatova OE
PROVIDER: S-EPMC10028257 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature
ACCESS DATA